Candel Therapeutics, Inc.
NASDAQ:CADL
7.755 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -37.939 | -18.794 | -36.124 | -17.68 | -8.24 |
| Depreciation & Amortization
| 1.2 | 0.778 | 0.232 | 0.091 | 0.043 |
| Deferred Income Tax
| -0.045 | 0 | 11.511 | 4.605 | 0 |
| Stock Based Compensation
| 3.091 | 2.307 | 2.963 | 2.107 | 0.4 |
| Change In Working Capital
| -0.525 | 0.071 | -0.876 | 1.774 | 0.513 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0.045 | -1.213 | 0.669 | 0.289 | 0.013 |
| Other Working Capital
| -0.57 | 1.284 | -1.545 | 1.485 | 0.5 |
| Other Non Cash Items
| -0.026 | -15.781 | 0.076 | 0.032 | 2.107 |
| Operating Cash Flow
| -34.244 | -31.419 | -22.218 | -9.071 | -5.177 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -0.457 | -1.297 | -1.835 | -1.476 | -0.159 |
| Acquisitions Net
| 0.177 | 0 | 0 | -39.931 | -0.846 |
| Purchases Of Investments
| 0 | 0 | 0 | -0.006 | -39.107 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 39.937 | 4.371 |
| Other Investing Activites
| 0.177 | 0 | 0 | 39.931 | -34.736 |
| Investing Cash Flow
| -0.28 | -1.297 | -1.835 | 38.455 | -35.741 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | -19.91 | 0 | -0.46 | -0.522 |
| Common Stock Issued
| 0 | 0.064 | 71.335 | 0.03 | 22.501 |
| Common Stock Repurchased
| -0.121 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.121 | 39.82 | 0.465 | 0.92 | 21.979 |
| Financing Cash Flow
| -0.121 | 19.974 | 71.8 | 0.49 | 21.979 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -34.645 | -12.742 | 47.747 | 29.874 | -18.939 |
| Cash At End Of Period
| 35.413 | 70.324 | 83.066 | 35.319 | 5.445 |